ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,334.11
0.13%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Australia
  5. ASX

  6. Cynata Therapeutics Ltd (CYP) Cotización

Cynata Therapeutics Ltd

Cynata Therapeutics Ltd (CYP)

Cypress Development Corp
0.2325
-0.0075
(-3.12%)
Cerrado 05 Enero 11:00PM
Delayed by 20 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
0.2325
Postura de Compra
0.225
Postura de Venta
0.235
Volume Operado de la Acción
126,348
0.23 Rango del Día 0.24
0.12 Rango de 52 semanas 0.345
Capitalización de Mercado [m]
41.764M
Precio Anterior
0.24
Precio de Apertura
0.2375
Hora
1720
@
0.2325
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
224,011
Acciones en circulación
179,631,786
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-4.24
Beneficio por acción (BPA)
-0.05
turnover
-
Beneficio neto
-9.75M

Acerca de Cynata Therapeutics Ltd

Sector
Health & Allied Services,nec
Industria
Nonwoven Fabrics
Sitio web
www.cynata.com
Sede
Melbourne, Victoria, Aus
Fundado
2013
Cynata Therapeutics Ltd is listed in the Health & Allied Services sector of the Australian Stock Exchange with ticker CYP. The last closing price for Cynata Therapeutics was AUD0.24. Over the last year, Cynata Therapeutics shares have traded in a share price range of AUD 0.12 to AUD 0.345.

Cynata Therapeutics currently has 179,631,786 shares in issue. The market capitalisation of Cynata Therapeutics is AUD43.11 million. Cynata Therapeutics has a price to earnings ratio (PE ratio) of -4.24.

CYP Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.022510.71428571430.210.2550.213082640.2301488DE
40.00753.333333333330.2250.2550.175899860.20068271DE
12-0.0275-10.57692307690.260.260.172240110.20735052DE
26-0.0625-21.1864406780.2950.2950.171479270.21469273DE
520.102578.84615384620.130.3450.121494510.21397593DE
156-0.3125-57.33944954130.5450.60.1051139790.23041236DE
260-0.8075-77.64423076921.041.30.1051570580.50180092DE

CYP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cynata Therapeutics?
El precio actual de las acciones de Cynata Therapeutics es AUD 0.2325
¿Cuántas acciones de Cynata Therapeutics están en circulación?
Cynata Therapeutics tiene 179,631,786 acciones en circulación
¿Cuál es la capitalización de mercado de Cynata Therapeutics?
La capitalización de mercado de Cynata Therapeutics es AUD 43.11M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cynata Therapeutics?
Cynata Therapeutics ha negociado en un rango de AUD 0.12 a AUD 0.345 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cynata Therapeutics?
El ratio precio/beneficio de Cynata Therapeutics es -4.24
¿Cuál es la moneda de reporte de Cynata Therapeutics?
Cynata Therapeutics presenta sus resultados financieros en AUD
¿Cuál es el último beneficio anual de Cynata Therapeutics?
El último beneficio anual de Cynata Therapeutics es AUD -9.75M
¿Cuál es la dirección registrada de Cynata Therapeutics?
La dirección registrada de Cynata Therapeutics es LEVEL 3, 62 LYGON STREET, CARLTON, VICTORIA, MELBOURNE, VICTORIA, 3053
¿Cuál es la dirección del sitio web de Cynata Therapeutics?
La dirección del sitio web de Cynata Therapeutics es www.cynata.com
¿En qué sector industrial opera Cynata Therapeutics?
Cynata Therapeutics opera en el sector NONWOVEN FABRICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
IBGIronbark Zinc Limited
AUD 0.255
(8,400.00%)
113.37k
KATOKatana Capital
AUD 0.003
(200.00%)
77.1k
TTMOTitan Minerals Limited
AUD 0.03
(87.50%)
12.33k
EELENRG Elements Ltd
AUD 0.0015
(50.00%)
10M
CCOOAThe Calmer Co International Ltd
AUD 0.0015
(50.00%)
2.21M
NRZONeuRizer Ltd
AUD 0.001
(-50.00%)
1.01M
EATEntertainment Rewards Ltd
AUD 0.002
(-50.00%)
968.35k
NACONAOS Ex50 Opportunities Company Limited
AUD 0.002
(-33.33%)
13.37k
PNTOAPanther Metals Ltd
AUD 0.002
(-33.33%)
47k
KNBOKoonenberry gold Ltd
AUD 0.005
(-28.57%)
1.63M
GCMGreen Critical Minerals Ltd
AUD 0.019
(5.56%)
117.1M
ROGRed Sky Energy Limited
AUD 0.009
(-14.29%)
74.61M
IMUImugene Limited
AUD 0.039
(4.00%)
46.15M
BRNBrainchip Holdings Ltd
AUD 0.415
(-4.05%)
35.04M
TMGTrigg Minerals Ltd
AUD 0.045
(4.65%)
28.2M

Discusión

Ver feed completo
axelvento axelvento 21 minutos hace
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 24 minutos hace
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 25 minutos hace
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 26 minutos hace
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 27 minutos hace
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 28 minutos hace
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 29 minutos hace
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 30 minutos hace
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 31 minutos hace
Probably
AVXL
HokieHead HokieHead 33 minutos hace
Wrong..
TWOH
HokieHead HokieHead 33 minutos hace
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 35 minutos hace
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 36 minutos hace
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 37 minutos hace
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 38 minutos hace
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 38 minutos hace
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 39 minutos hace
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 39 minutos hace
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 42 minutos hace
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL
facts_matter14 facts_matter14 43 minutos hace
Looks like Baggy is worried about Maxine not showing up at CES this week…………….









.
SRMX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 43 minutos hace
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

OK so we should see the test start this quarter then?
AVXL
Canna_Business Canna_Business 44 minutos hace
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
mrfence mrfence 44 minutos hace
Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
GME

Su Consulta Reciente

ASX
CYP
Cynata Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados